Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license
A 2010 meta-analysis of up to 122,744 people without diabetes found 16 loci shaping fasting glucose as a continuous measurement — related to, but distinct from, the diagnosis of type 2 diabetes.
Fasting blood glucose is the blood sugar level measured after a period without eating, one of the standard tests used to screen for and monitor diabetes. Like most physiological measurements, it varies continuously across the population — most people are not diabetic, but everyone has some fasting glucose level, and genetics shapes part of that variation even among people who will never develop diabetes. This page is about that continuous measurement specifically, distinct from this site's separate Type 2 Diabetes page, which covers disease-risk variants in people who do and don't develop the condition.
Dupuis et al. 2010, the MAGIC consortium, meta-analysed 21 genome-wide association studies covering up to 46,186 nondiabetic participants, with follow-up in up to 76,558 more, to study fasting glucose, fasting insulin, and two related indices of how well the body handles glucose (beta-cell function and insulin resistance). The study found 16 loci for fasting glucose and beta-cell function, 9 of them newly identified at the time — including rs11920090 in SLC2A2, rs7944584 in MADD, and rs11605924 in CRY2, all named directly in the paper — plus 2 more loci for fasting insulin and insulin resistance.
The study went further than just cataloguing loci for the continuous measurement: it separately tested whether the same variants were also associated with type 2 diabetes itself, and confirmed several were (including PROX1 and GCKR) — while explicitly noting that some loci raise fasting glucose modestly without being associated with overt diabetes. That distinction is exactly why this page exists separately from the diabetes page: a variant that nudges a measurement is not the same claim as a variant that raises disease risk, even when the same gene sometimes does both.
Two more of this page's variants are worth naming directly: rs12243326, in TCF7L2 — the single most consistently replicated type 2 diabetes gene in human genetics, though this specific variant is tagged here for its effect on the continuous glucose measurement rather than disease odds — and rs34177044 and rs2232326, both in G6PC2, a gene that directly controls how much glucose the liver releases into the blood.
2026-05-22 · Sinnott-Armstrong N, et al., Nature Communications 2026, PMID:42173832
Genetic variants affect diurnal glucose levels throughout the day
Circadian rhythms regulate glucose metabolism as well as sleep, but which genetic variants govern the timing of glucose had not been examined. Using the time of day each blood sample was taken, this study of about 420,000 UK Biobank participants — replicated in the Estonian Biobank, FinnGen, the VA Million Veteran Program and the MGB Biobank — shows that glucose levels are under diurnal genetic control. The two robust time-dependent signals are at MTNR1B, the melatonin receptor (rs10830963), and at CRY2, a core circadian clock gene (rs12419690). Sleep modulated glucose levels, the variants acted independently of sleep, they independently changed the risk of type 2 diabetes, and sleep medications including melatonin were associated with type 2 diabetes. Those two headline positions are not on this site yet; 21 other positions from the study are, among them rs560887 (G6PC2), rs34872471 (TCF7L2), rs3802177 (SLC30A8) and rs11708067 (ADCY5). PMID:42173832.
Fasting glucose is measured directly with a blood test, not estimated from genotype, and this page's variants are not used by any guideline to diagnose diabetes or prediabetes. The variants here describe why fasting glucose varies among people who do not have diabetes — not who will go on to develop it.
Diabetes and prediabetes are diagnosed using standard fasting glucose, oral glucose tolerance, or HbA1c thresholds set by clinical guidelines — not genotype. Nothing on this page changes how those tests are interpreted or how diabetes risk is clinically assessed; for disease-specific genetics, see this site's Type 2 Diabetes page.
The studies behind these variants recruited participants from different ancestries — a result found in one population doesn't always transfer to another. Based on 12 of 95 linked studies with a resolved discovery ancestry.
Databases, guidelines and references
Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license
Fasting Blood Glucose. MyGeneLog™. https://www.mygenelog.com/conditions/fasting-blood-glucose
Fasting blood glucose is blood sugar measured after a period without eating — a continuous measurement everyone has, whether or not they have diabetes. This page covers genetic variants affecting that measurement specifically, distinct from this site's separate page on type 2 diabetes, the diagnosed disease.
Studying up to 122,744 people without diabetes combined across discovery and follow-up, it found 16 loci associated with fasting glucose and beta-cell function, 9 of them newly identified, including SLC2A2, MADD, and CRY2.
Not on their own. The study specifically found that some loci raise fasting glucose modestly without being associated with overt diabetes — a nudge to a measurement, not a diagnosis.
No individual variant does. These are population-level statistical associations from a study of people without diabetes, and fasting glucose is measured directly with a blood test, not estimated from genotype.
Free to reuse, non-commercially. This page's text is original writing from freely-available research, licensed CC BY-NC 4.0 — share and adapt it with attribution to MyGeneLog™; commercial use is licensed. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.